Novel research from the University of Alicante, Spain has suggested that the administration of proinsulin may be capable of slowing retinal degeneration and vision loss in a model of retinitis pigmentosa. The research study, led by Drs. Laura Fernandez-Sanchez and Nicolas Cuenca, reported that a single systemic injection appeared to reduce the level of visual deterioration and led to a significant preservation of photoreceptor cells compared to control tests. The authors of the work describe the study as the first proinsulin therapy in an animal model using a gene therapy approach.
New research suggests proinsulin administration may reduce vision loss in retinitis pigmentosa models
- by swdadmin